<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Fouladseresht H</submitter><funding>Shahid Beheshti University of Medical Sciences</funding><pubmed_abstract>Although cellular and molecular mediators of the immune system have the potential to be prognostic indicators of disease outcomes, temporal interference between diseases might affect the immune mediators, and make them difficult to predict disease complications. Today one of the most important challenges is predicting the prognosis of COVID-19 in the context of other inflammatory diseases such as traumatic injuries. Many diseases with inflammatory properties are usually polyphasic and the kinetics of inflammatory mediators in various inflammatory diseases might be different. To find the most appropriate evaluation time of immune mediators to accurately predict COVID-19 prognosis in the trauma environment, researchers must investigate and compare cellular and molecular alterations based on </pubmed_abstract><journal>Frontiers in immunology</journal><pagination>785946</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8815083</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.</pubmed_title><pmcid>PMC8815083</pmcid><pubmed_authors>Fouladseresht H</pubmed_authors><pubmed_authors>Eskandari N</pubmed_authors><pubmed_authors>Norouzian M</pubmed_authors><pubmed_authors>Ghezelbash B</pubmed_authors><pubmed_authors>Beyranvand MR</pubmed_authors><pubmed_authors>Nejadghaderi SA</pubmed_authors><pubmed_authors>Safiri S</pubmed_authors><pubmed_authors>Ghamar Talepoor A</pubmed_authors><pubmed_authors>Kolahi AA</pubmed_authors><pubmed_authors>Carson-Chahhoud K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities.</name><description>Although cellular and molecular mediators of the immune system have the potential to be prognostic indicators of disease outcomes, temporal interference between diseases might affect the immune mediators, and make them difficult to predict disease complications. Today one of the most important challenges is predicting the prognosis of COVID-19 in the context of other inflammatory diseases such as traumatic injuries. Many diseases with inflammatory properties are usually polyphasic and the kinetics of inflammatory mediators in various inflammatory diseases might be different. To find the most appropriate evaluation time of immune mediators to accurately predict COVID-19 prognosis in the trauma environment, researchers must investigate and compare cellular and molecular alterations based on </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-04-25T17:12:35.374Z</modification><creation>2025-04-06T04:02:57.316Z</creation></dates><accession>S-EPMC8815083</accession><cross_references><pubmed>35126355</pubmed><doi>10.3389/fimmu.2021.785946</doi></cross_references></HashMap>